This trial is testing a new drug for people with NASH, a liver disease, who also have a certain risk allele. The study will see if the drug is safe and effective.
- Non-alcoholic Fatty Liver Disease (NAFLD)
1 Primary · 50 Secondary · Reporting Duration: Day 1 and Day 57: Pre-dose and between 0-6 hours, 6-12 hours, 12-24 hours, 24-36 hours and 36-48 hours post-dose
4 Treatment Groups
1 of 4
1 of 4
1 of 4
1 of 4
72 Total Participants · 4 Treatment Groups
Primary Treatment: AZD2693 · Has Placebo Group · Phase 1
Who is running the clinical trial?
Age 18 - 75 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||50.0%|
How many prior treatments have patients received?
Frequently Asked Questions
At how many sites is this empirical investigation being conducted?
"This clinical trial is currently enrolling patients from 17 sites, which are located in Washington, Durham and Indianapolis as well as other cities. It might be beneficial to pick the nearest location to avoid extensive travelling if you decide to join this study." - Anonymous Online Contributor
How many participants are being taken into consideration for this research?
"Affirmative. Clinicaltrials.gov reveals that the medical trial, initially posted on November 6th 2020, is now actively recruiting subjects for participation. Seventeen sites will require 80 participants in total." - Anonymous Online Contributor
Is there an age restriction to be eligible for the trial?
"According to the prerequisites for this medical study, willing participants must be 18 years old or older and no greater than 75 years of age." - Anonymous Online Contributor
Has AZD2693 been granted regulatory authorization from the FDA?
"Data on AZD2693's safety and efficacy is limited, thus our team awarded it a score of 1." - Anonymous Online Contributor
What is the ideal demographic to recruit for this research project?
"Prospective participants of this study must meet the criteria of having steatohepatitis and falling within the age range 18 to 75. The trial seeks inclusion for a total 80 individuals." - Anonymous Online Contributor
Are there any open slots for participation in this scientific investigation?
"Affirmative. According to clinicaltrials.gov, this therapeutic trial is currently seeking applicants and was originally posted on November 6th 2020 with a most recent edit occurring on November 2nd 2022. Eighty participants will be enrolled from 17 different sites in total." - Anonymous Online Contributor